Digital Regulators open the AI floodgates in life sciences In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.
R&D Future glances: More change, more tech, more harmonisation According to Deloitte’s 2026 Life Sciences Outlook Survey, the life sciences sector might be becoming increasingly borderless, but only 41% of responding biopharma and medtech executives fe
News FDA doubles down on its push into AI The FDA has revealed the latest element in its adoption of AI, an agentic AI platform that agency staffers can use to streamline complex tasks.
Digital From weeks to minutes: How AI transforms pharmaceutical mark... Agentic AI isn’t just another analytical instrument. It represents a reimagining of how strategic intelligence is generated and applied.
R&D Leveraging AI agents to eliminate ‘white space’ in clinical ... Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.
Digital From fragmented to focused: Transforming field engagement wi... The promise of agentic AI extends beyond operational efficiency, freeing field teams from administrative burdens and empowering them.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
